noscript

News and Announcements

Analytica (ASX: ALT) Annual Update 2015; Receives 510(k) Clearance with FDA & Raises $2.9m

  • Published December 16, 2015 4:05PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

In 2015, Analytica (ASX:ALT) achieved a critical regulatory milestone receiving 510(k) clearance with the US FDA for the PeriCoach, which along with Australian and European approval, allows the company to sell the product globally. Analytica also undertook a rights issue which raised $2.9 million. The company increased its US sales and marketing efforts with a distribution agreement with Currently Technology Inc and a partnership with SalesForce4Hire. Analytica has an exciting year ahead as it drives towards a licensing deal, identifies new market and commercialization opportunities for PeriCoach and accelerates research and development efforts to make further enhancements to the product.

ABOUT ANALYTICA

Analytica Ltd (ASX: ALT) is an Australian medical device manufacturing and commercialisation company. Its lead product, the PeriCoach System, is a novel medical device to treat stress urinary incontinence (SUI) – a condition with significant unmet medical need and huge market potential.

PeriCoach is a medical device that measures the muscles that matter when treating stress urinary incontinence and increases pelvic muscle strength. The device is low-risk with low manufacturing cost and readily scalable production. Analytica already has regulatory approval in US, Europe and Australia with sales underway.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now